We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Cardiology

Journal Scan / Research · April 01, 2021

Effects of IL-6 Receptor Antibodies on Systemic Inflammatory Response After Out-of-Hospital Cardiac Arrest



Additional Info

Disclosure statements are available on the authors' profiles:

Treatment Effects of Interleukin-6 Receptor Antibodies for Modulating the Systemic Inflammatory Response After Out-of-Hospital Cardiac Arrest (The IMICA Trial): A Double-Blinded, Placebo-Controlled, Single-Center, Randomized Clinical Trial
Circulation 2021 Mar 22;[EPub Ahead of Print], MAS Meyer, S Wiberg, J Grand, ASP Meyer, LER Obling, M Frydland, JH Thomsen, J Josiassen, JE Møller, J Kjaergaard, C Hassager

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading